Mind Medicine Stock Price on December 2, 2024
| MNMD Stock | USD 7.15 0.14 1.92% |
Below is the normalized historical share price chart for Mind Medicine extending back to November 15, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Mind Medicine stands at 7.15, as last reported on the 11th of December 2024, with the highest price reaching 7.36 and the lowest price hitting 7.06 during the day.
If you're considering investing in Mind Stock, it is important to understand the factors that can impact its price. Mind Medicine appears to be moderately volatile, given 3 months investment horizon. Mind Medicine has Sharpe Ratio of 0.0713, which conveys that the firm had a 0.0713% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Mind Medicine, which you can use to evaluate the volatility of the firm. Please exercise Mind Medicine's Risk Adjusted Performance of 0.0651, mean deviation of 3.64, and Downside Deviation of 3.88 to check out if our risk estimates are consistent with your expectations.
At present, Mind Medicine's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. . As of December 11, 2024, Price Earnings Ratio is expected to decline to -1.57. In addition to that, Price Book Value Ratio is expected to decline to 1.82. Mind Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of March 2020 | 200 Day MA 7.6198 | 50 Day MA 6.7706 | Beta 2.332 |
Mind |
Sharpe Ratio = 0.0713
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MNMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.86 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.35 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Mind Medicine is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mind Medicine by adding it to a well-diversified portfolio.
Price Book 2.0375 | Book Value 3.214 | Enterprise Value 263.2 M | Enterprise Value Ebitda (6.57) | Shares Float 59.3 M |
Related Headline
Iteos Therapeutics Headline on 2nd of December 2024
iTeos Therapeutics, Inc. Shares Purchased by Clearline Capit... by thelincolnianonline.com
Clearline Capital LP boosted its position in shares of iTeos Therapeutics, Inc. by 6.7 percent during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The firm owned 167,417 shares of the companys stock after purchasing an additional 10,523 shares during the period.
Mind Medicine Valuation on December 2, 2024
It is possible to determine the worth of Mind Medicine on a given historical date. On December 2, 2024 Mind was worth 8.28 at the beginning of the trading date compared to the closed value of 8.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Mind Medicine stock. Still, in general, we apply an absolute valuation method to find Mind Medicine's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mind Medicine where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Mind Medicine's related companies.
| Open | High | Low | Close | Volume | |
| 8.30 | 8.42 | 7.92 | 8.17 | 656,304 | |
12/02/2024 | 8.28 | 8.56 | 8.12 | 8.14 | 1,142,514 |
| 8.10 | 8.29 | 7.26 | 7.49 | 1,337,450 |
| Backtest Mind Medicine | | | Mind Medicine History | | | Mind Medicine Valuation | Previous | Next |
Mind Medicine Trading Date Momentum on December 2, 2024
| On December 03 2024 Mind Medicine was traded for 7.49 at the closing time. The top price for the day was 8.29 and the lowest listed price was 7.26 . The trading volume for the day was 1.3 M. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 7.99% . The trading delta at closing time against the current closing price is 10.81% . |
Mind Medicine Fundamentals Correlations and Trends
By evaluating Mind Medicine's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Mind Medicine's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Mind financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Mind Medicine Stock history
Mind Medicine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mind is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mind Medicine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mind Medicine stock prices may prove useful in developing a viable investing in Mind Medicine
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 39.2 M | 25.4 M | |
| Net Loss | -51.1 M | -53.7 M |
Mind Medicine Quarterly Net Working Capital |
|
Mind Medicine Stock Technical Analysis
Mind Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Mind Medicine Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Mind Medicine cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Mind Medicine December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Mind Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mind Medicine shares will generate the highest return on investment. By undertsting and applying Mind Medicine stock market strength indicators, traders can identify Mind Medicine entry and exit signals to maximize returns
Mind Medicine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mind Medicine's price direction in advance. Along with the technical and fundamental analysis of Mind Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mind to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0651 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0644 | |||
| Treynor Ratio | 0.1129 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Mind Stock analysis
When running Mind Medicine's price analysis, check to measure Mind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mind Medicine is operating at the current time. Most of Mind Medicine's value examination focuses on studying past and present price action to predict the probability of Mind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mind Medicine's price. Additionally, you may evaluate how the addition of Mind Medicine to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |